πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 120 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8859774

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8829024

Combination steroid and glucocorticoid receptor antagonist therapy

Corcept Therapeutics Incorporated Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8741880

Antiglucocorticoid therapy for the prevention of neurological damage in premature infants

Corcept Therapeutics Incorporated Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8685973

Pyrimidine cyclohexyl glucocorticoid receptor modulators

Corcept Therapeutics Incorporated Β· Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8598149

Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders

Corcept Therapeutics Incorporated Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8598154

Pyridyl-amine fused azadecalin modulators

Corcept Therapeutics Incorporated Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8557839

Fused ring azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated Β· Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8476254

Methods for treating psychosis associated with interferson-Ξ± therapy

Corcept Therapeutics Incorporated Β· Granted Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8461172

Solid forms and process for preparing

Corcept Therapeutics Incorporated Β· Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8450379

Methods for treating migraine

Corcept Therapeutics Incorporated Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8324203

Azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173664

Modified pyrimidine glucocorticoid receptor modulators

Corcept Therapeutics Incorporated Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8097606

Antiglucocorticoids for the treatment of catatonia

Corcept Therapeutics Incorporated Β· Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928237

Fused ring azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated Β· Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884091

Methods for treating delirium using glucocorticoid receptor-specific antagonists

Corcept Therapeutics Incorporated Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678813

Azadecalin Glucocorticoid receptor modulators

Corcept Therapeutics Incorporated Β· Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7576076

Modified pyrimidine glucocorticoid receptor modulators

Corcept Therapeutics Incorporated Β· Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7402578

Methods for inhibiting cognitive deterioration in adults with down's syndrome

Corcept Therapeutics Incorporated Β· Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7361646

Methods for treating gastroesophageal reflux disease

Corcept Therapeutics Incorporated Β· Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7326697

Methods for increasing the therapeutic response to electroconvulsive therapy

Corcept Therapeutics Incorporated Β· Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7163934

Methods for treating delirium glucocorticoid receptor-specific antagonists

Corcept Therapeutics Incorporated Β· Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6964953

Methods for treating stress disorders using glucocorticoid receptor-specific antagonists

Corcept Therapeutics Incorporated Β· Granted Tue Nov 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6680310

Methods for preventing antipsychotic-induced weight gain

Corcept Therapeutics Incorporated Β· Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6620802

Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor ant

Corcept Therapeutics Incorporated Β· Granted Tue Sep 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired